Holen Sie sich die Stockscreener-App
114.19
2.49%
2.77
Handel nachbörslich:
113.75
-0.44
-0.39%
Schlusskurs vom Vortag:
$111.42
Offen:
$110.06
24-Stunden-Volumen:
660.87K
Relative Volume:
0.38
Marktkapitalisierung:
$8.72B
Einnahmen:
$8.10B
Nettoeinkommen (Verlust:
$599.48M
KGV:
15.44
EPS:
7.3969
Netto-Cashflow:
$971.54M
1W Leistung:
+10.78%
1M Leistung:
+5.47%
6M Leistung:
-40.82%
1J Leistung:
-32.31%
1-Tages-Spanne:
$108.58
$115.62
1-Wochen-Bereich:
$100.94
$115.62
52-Wochen-Spanne:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
114.19 | 8.72B | 8.10B | 599.48M | 971.54M | 7.3969 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-26 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2026-02-23 | Hochstufung | Jefferies | Hold → Buy |
| 2026-02-18 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-17 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-12 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | Herabstufung | Truist | Buy → Hold |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-09 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-03 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
ICON PLC earnings missed by $0.02, revenue was in line with estimates - Investing.com Australia
ICLR 3-Year EBITDA Growth Rate: 28.40% — 176% Above Median - gurufocus.com
MEX:ICLR EV-to-OCF: 9.32 — 56% Below Median - gurufocus.com
Icon PLC Forges Strategic Alliance Amidst Financial Review - AD HOC NEWS
Icon Plc $ICLR Shares Bought by Allspring Global Investments Holdings LLC - marketbeat.com
Icon PLC (ICLR) Stock Price Up 3.93% on Mar 30 - GuruFocus
Precision Trading with Icon Plc (ICLR) Risk Zones - Stock Traders Daily
Is ICON Public Limited Company (ICLR) A Good Stock To Buy Now? - Insider Monkey
ICON Stock Trades At Deep Discount Amid Probe - Let's Data Science
Icon Plc (NASDAQ:ICLR) Given Consensus Rating of "Hold" by Brokerages - marketbeat.com
Why ICON (ICLR) Is Up 5.1% After New AI-Powered Clinical Trial Partnership With Advarra - simplywall.st
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Journey Medical Corp (DERM) - The Globe and Mail
Clinical research provider Icon stock crashes on accounting probe - MSN
ICON (ICLR) Upgraded by BMO Capital Markets Amid Valuation Appea - GuruFocus
Icon plc buy BMO Capital Markets - sharewise.com
ICON PLC : BMO Raises to Outperform From Mark - Moomoo
BMO Capital Upgrades Icon PLC(ICLR.US) to Buy Rating, Cuts Target Price to $130 - 富途牛牛
BMO upgrades ICON stock rating on pharma backdrop improvement - Investing.com UK
Strategic Partnership Aims to Boost Icon's Efficiency Amid Accounting Scrutiny - AD HOC NEWS
WGI DM, LLC's Icon PLC(ICLR) Holding History - GuruFocus
Icon, Advarra enter partnership, introduces ‘research-ready’ site network model - TipRanks
ICON, Advarra Partner on Connected Site Network Model - Contract Pharma
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model (1) - PharmiWeb.com
Rep. Julia Letlow Sells Icon Plc (NASDAQ:ICLR) Stock - MarketBeat
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model - Business Wire
JPMorgan Chase & Co. Sells 614,165 Shares of Icon Plc $ICLR - MarketBeat
ICLR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
ICON set to report delayed earnings after accounting scandal - Investing.com UK
ICON set to report delayed earnings after accounting scandal By Investing.com - Investing.com UK
ICON (ICLR) Is Down 7.8% After Revenue Overstatement Disclosure And Accounting ReviewHas The Bull Case Changed? - Yahoo Finance
Icon Plc $ICLR is Wgi Dm LLC's 4th Largest Position - marketbeat.com
Hudson Bay Capital Management LP Sells 79,000 Shares of Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) CEO details stock option and RSU holdings - Stock Titan
ICON PLC (ICLR) CFO lists RSU and stock option holdings in Form 3 - Stock Titan
ICON PLC (ICLR) director Stephen Cutler reports 79,278 shares and options - Stock Titan
[Form 3] ICON PLC Initial Statement of Beneficial Ownership - Stock Titan
ICON PLC (ICLR) director Linda Grais reports initial share and RSU holdings - Stock Titan
Director Anne Whitaker reports 1,732 ICON PLC (ICLR) restricted share units - Stock Titan
Julie O’Neill (ICLR) details initial ICON PLC share and RSU holdings - Stock Titan
ICON PLC (ICLR) director details shares, RSUs and option holdings - Stock Titan
ICON PLC (NASDAQ: ICLR) director Ronan Murphy details share and option holdings - Stock Titan
ICON PLC (ICLR) director Climax details options, RSUs and share stakes - Stock Titan
ICON PLC (ICLR) director reports initial Form 3 equity holdings - Stock Titan
CIBC Bancorp USA Inc. Invests $39.07 Million in Icon Plc $ICLR - MarketBeat
ICON plc Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Holocene Advisors LP Sells 287,221 Shares of Icon Plc $ICLR - MarketBeat
Lowey Dannenberg Investigating ICON PLC for Potential Securities Violations - National Today
Lowey Dannenberg Investigating ICON PLC for Potential Securities Law Violations - National Today
Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - marketscreener.com
Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: - GlobeNewswire
Icon Plc $ICLR Shares Sold by Fayez Sarofim & Co - MarketBeat
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):